Getting Real with RWE
By Taren Grom Real-world evidence, important for regulatory decision-making, is beginning to touch all areas…
CertaraNovember 20, 2020
How PBPK Modeling Can Replace Drug-Drug Interaction Studies
Patients often take more than one drug at a time, especially elderly patients and those…
CertaraNovember 12, 2020
Certara Opens New China Office in Shanghai
Office will support rapid growth and collaboration with customers in China to accelerate biopharmaceutical R&D …
CertaraNovember 9, 2020
PBPK modeling supports approval of breakthrough cancer drug
Pharmacyclics’ (now AbbVie) Imbruvica (ibrutinib) is an anticancer drug targeting B-cell malignancies. Leveraging the US…
CertaraOctober 23, 2020
